AI tool aims to predict liver cancer return after surgery
NCT ID NCT07062380
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is testing an artificial intelligence (AI) model to see if it can predict whether early-stage liver cancer will come back within two years after surgery. About 353 adults with early-stage liver cancer will have standard surgery and then be monitored with scans. Their medical data and images will be used to train and check the AI's predictions. The goal is to improve follow-up care by identifying high-risk patients earlier.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this AI tool could help doctors identify patients at high risk of cancer recurrence early, allowing for closer monitoring or timely treatment adjustments.
What could go wrong
This is an observational study, not a treatment trial. The AI model may not be accurate enough for real-world use, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATECTOMY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongji Hospital
RECRUITINGWuhan, Hubei, 430030, China
Contact Phone: •••-•••-•••• Email: •••••@•••••